Friday, 16 November 2018

Ajanta, Aurobindo, Sun Pharma gets tentative FDA approval of Tadalafil

24 May 2018 | News

Tadalafil is manufactured by Eli Lilly and it is sold under two brands as Cialis and Adcirca

Tadalafil, an oral drug that is used for treating impotence, has seen the first wave of approvals and Indian companies - Ajanta, Aurobindo and Sun Pharma, all have seen tentative approvals in this.

Tadalafil is manufactured by Eli Lilly and it is sold under two brands as Cialis and Adcirca.

Adcirca and Cialis will lose their first patent in 2018 and last patent in 2021. Cialis also has pediatric exclusivity which will expire in 2021.

Cialis reported annual sales of $2.3bn and Adcirca reported sales of $290mn in 2017. Teva has received final approval in the first wave.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Click Here!




Survey Box

Will the health insurance sector receive benefits from Ayushman Bharat?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls